Delivery Order SPE2DB22D1103-SPE2DB25FH2H7
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,347.67 on August 19, 2025, for the supply of Triamterene-HCTZ 75-50 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price contract is scheduled for completion by August 20, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Triamterene-HCTZ 37.5-25 mg tablets in a quantity of 500 units, with a ceiling value of $1,267.99. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a $1,599.89 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Triamterene-HCZ 75-50 mg tablets (500 count units) with an ultimate completion date of August 25, 2025. This delivery order utilizes firm fixed pricing and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This award is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Triamterene-HCZ 37.5-25 mg, with a ceiling value of $1,007.51. The contract was awarded on October 17, 2025, with an ultimate completion date of October 20, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,085.19 to AmerisourceBergen Drug Corp for 500 tablets of Triamterene-HCTZ 37.5-25 mg, a generic combination diuretic medication commonly used in the treatment of hypertension. Awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed price delivery order represents a routine pharmaceutical procurement under a non-set-aside competitive award. The contract will be performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,093.40 for Triamterene 50 mg capsules (100 count) with a completion date of June 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.35 firm fixed-price delivery order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a cardiovascular medication. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,775.38 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,483,277 units of triamterene 50 mg capsules in 100-count bottles. This delivery order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,235.12 firm fixed price contract is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,003.27, is a delivery order with a firm fixed price pricing type. It is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition....
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2H7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,304.27 to AmerisourceBergen Drug Corp for the supply of Triamterene-HCTZ 37.5-25 mg tablets in quantities of 100 per unit. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical supply vehicle enables the company to deliver a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical vendor supplying generic and brand-name medications, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/15/25 |